OneMedNet Network Expands with New Partnership with Large Academic Research Medical Center to Benefit its Life Science Company Clients

Rhea-AI Summary

ONMD - OneMedNet Corporation Announces Partnership to Accelerate Life Science Innovation with Real World Data. The partnership aims to expand development of new diagnostic and treatment solutions using OneMedNet's iRWD, benefiting pharmaceutical, AI, medical device, and clinical research organizations. This collaboration will provide access to critical RWD for healthcare providers and Life Sciences, leveraging the expertise of over 200 healthcare systems and providers, including a top-ranked tertiary medical center with a leading cancer center.

Positive

• The partnership with a leading research medical center signifies OneMedNet's commitment to providing access to critical RWD for Life Science companies, expanding their network to 20 research centers and institutions, and offering significant data diversity, especially in oncology RWD, which is in high demand.

Negative

• None.

~ Partnership To Leverage Real World Data for Life Science Innovation Accelerating New Diagnostic and Treatment Solutions ~

MINNEAPOLIS, MN / ACCESSWIRE / November 9, 2023 / OneMedNet Corporation (Nasdaq:ONMD) ("OneMedNet"), the leading curator of regulatory-grade imaging Real World Data ("RWD"), today announced a new partnership with a leading research medical center to accelerate and expand development of new diagnostic and treatment solutions using OneMedNet's iRWD™. Life Science innovators, including pharmaceutical, AI, medical device, and clinical research organizations, are now able to effectively use existing real world data for discovery, development, regulatory-approval, and post-market surveillance.

"This is great news for OneMedNet who is committed to providing our Life Science company clients with access to the critical RWD they need to succeed. The challenge for Life Science companies is not the utilization of RWD in their processes, but obtaining the highly specific data that unequivocally meets all of their required data attributes," said Aaron Green, OneMedNet President. "We've been safely and securely identifying, indexing and de-identifying imaging data for well over a decade. OneMedNet's leadership in providing the most current regulatory grade data has proven invaluable to both healthcare providers and Life Sciences."

This essential data which fuels technology and clinical advancement can sit idle and unproductive without healthcare providers engagement. Importantly, academic tertiary centers also offer significant data diversity which is a high priority for the Food and Drug Administration when reviewing regulatory submissions.

The OneMedNet iRWD™ network consists of over 200 healthcare systems and providers. The addition of this tertiary medical center expands OneMedNet's carefully compiled RWD to 20 research centers and institutions. The main hospital is ranked in the top 40 nationwide and features one of the leading cancer centers. Given that oncology RWD is of highest demand, this represents a significant OneMedNet network addition.

About OneMedNet Corporation

Founded in 2009, OneMedNet provides innovative solutions that unlock the significant value contained within the clinical image archives of healthcare providers. Employing its proven OneMedNet iRWD™ solution, OneMedNet securely de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with industry leading technology and in-house clinical expertise, OneMedNet successfully meets the most rigorous RWD Life Science requirements. For more information, please visit www.onemednet.com.

Investor Contact:

Shannon Devine
MZ Group North America
203-741-8811
ONMD@mzgroup.us

SOURCE: OneMedNet

View source version on accesswire.com:
https://www.accesswire.com/801774/onemednet-network-expands-with-new-partnership-with-large-academic-research-medical-center-to-benefit-its-life-science-company-clients

FAQ

What is the purpose of the partnership announced by OneMedNet Corporation (ONMD)?

The partnership aims to accelerate and expand the development of new diagnostic and treatment solutions using OneMedNet's iRWD, benefiting pharmaceutical, AI, medical device, and clinical research organizations.

How many healthcare systems and providers are part of OneMedNet's iRWD network?

Over 200 healthcare systems and providers are part of OneMedNet's iRWD network, with the addition of a top-ranked tertiary medical center expanding the network to 20 research centers and institutions.

Why is the addition of the tertiary medical center significant for OneMedNet?

The addition of the tertiary medical center offers significant data diversity, especially in oncology RWD, which is in high demand, representing a significant network addition for OneMedNet.

What challenges does OneMedNet aim to address with this partnership?

OneMedNet aims to address the challenge of obtaining highly specific data that unequivocally meets all required data attributes for Life Science companies in their processes.